Locations
Palo Alto, CA, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Other
founded in
2021
Surf Bio is a preclinical biopharmaceutical company founded in 2021, focused on transforming the delivery of biologics through its innovative Surf Snap Shot™ technology. This technology allows for the rapid administration of high concentrations of monoclonal antibodies via subcutaneous injection, significantly improving patient experience by enabling at-home self-administration instead of lengthy IV infusions. Surf Bio's proprietary polymer formulation enhances the accessibility and convenience of biologic therapies, positioning the company as a leader in the biopharmaceutical delivery space. With a strong team of experienced professionals and ongoing collaborations with major pharmaceutical companies, Surf Bio is well-positioned to make a significant impact in the market.
Something looks off?